BMC Research Notes · 2021 · 18 citations · 33 references
Life SciencesImmunologyMicrobiologyHost-pathogen InteractionsInflammationInnate ImmunityGastrointestinal InflammationGut MicrobiomeGut MicrobiotaInflammatory Bowel DiseaseInflammatory SignalingProbioticsImmune Modulation By Gut MicrobesInflammatory Mediator PathwaysPro-inflammatory Mediator GenesProbiotic Effects On Gut MicrobiotaProbiotic MetabolitesToll-like Receptor SignalingToll-like Receptor Signaling PathwaysToll-like Receptor-mediated Innate Immune Response
OBJECTIVE: Gut-microbiota plays key roles in many aspects like the health and illness of humans. It's well proved that modification of gut microbiota by probiotics is useful for improving inflammatory bowel disease (IBD) conditions. According to recent studies, different types of bacterial metabolites can affect immune cells and inflammation conditions. The present study aimed to evaluate the anti-inflammatory effects of metabolites of E. coli Nissle1917. RESULTS: The cell-free supernatant could modulate TNF-α production and affected many crucial mediators in the Toll-like receptor (TLR) signaling pathway. Also, supernatant showed significant dose-dependent properties in this regard. In this study, the TLR signaling pathway was found among probable mechanisms by which probiotics can affect inflammatory situations. These findings provide additional evidence on the use of probiotic metabolites for inhibiting and down-regulating numerous key mediator factors in the TLR signaling pathway. Aberrant or dysfunctional TLR signaling contributes to the development of acute and chronic intestinal inflammatory pathways in IBD. Therefore, finding a component that can affect this process might be considered for therapeutic targets in IBD patients.
33
Masahiro Yamamoto, Shintaro Sato, Kiyotoshi Mori et al. · The Journal of Immunology · 2002 · 1.2K citations · Full text
Toll-Like Receptor-4 Promotes the Development of Colitis-Associated Colorectal Tumors
Masayuki Fukata, Anli Chen, Arunan S. Vamadevan et al. · Gastroenterology · 2007 · 615 citations · Full text
Life Sciences, Immunology, Oncology +14
Estefanía Muñoz-Atienza, Beatriz Gómez‐Sala, Carlos Araújo et al. · BMC Microbiology · 2013 · 236 citations · Full text